Nuveen Asset Management, LLC Veracyte, Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 712,694 shares of VCYT stock, worth $24.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

712,694

Previous 1,027,427 30.63%

Holding current value

$24.1 Million

Previous $22.8 Million 32.16%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$18.86 - $23.55 $5.94 Million - $7.41 Million	-314,733 Reduced 30.63%	712,694 $15.4 Million
Q1 2024 May 13, 2024	BUY	$21.0 - $29.1 $108,108 - $149,806	5,148 Added 0.5%	1,027,427 $22.8 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $1.48 Million - $2.15 Million	-75,003 Reduced 6.84%	1,022,279 $28.1 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $3.7 Million - $4.95 Million	165,505 Added 17.76%	1,097,282 $24.5 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $14,609 - $18,812	697 Added 0.07%	931,777 $23.7 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $13.4 Million - $18.2 Million	651,413 Added 232.92%	931,080 $20.8 Million
Q4 2022 Feb 14, 2023	BUY	$15.31 - $29.94 $229,206 - $448,231	14,971 Added 5.66%	279,667 $6.64 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $86,962 - $146,335	-5,245 Reduced 1.94%	264,696 $4.39 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $16,176 - $30,907	1,047 Added 0.39%	269,941 $5.37 Million
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $112,135 - $217,268	-5,111 Reduced 1.87%	268,894 $7.32 Million
Q4 2021 Feb 14, 2022	SELL	$36.09 - $53.79 $7.45 Million - $11.1 Million	-206,343 Reduced 42.96%	274,005 $11 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $1.61 Million - $2.39 Million	45,214 Added 10.39%	480,348 $24.6 Million
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $1.35 Million - $2.33 Million	-41,068 Reduced 8.62%	435,134 $17.4 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $2.31 Million - $4.23 Million	-51,943 Reduced 9.83%	476,202 $25.6 Million
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $104,845 - $199,686	-3,227 Reduced 0.61%	528,145 $25.8 Million
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $4.9 Million - $6.53 Million	183,168 Added 52.6%	531,372 $17.3 Million
Q2 2020 Aug 14, 2020	SELL	$19.49 - $28.11 $1.59 Million - $2.3 Million	-81,789 Reduced 19.02%	348,204 $9.02 Million
Q1 2020 May 14, 2020	SELL	$16.13 - $30.17 $1.96 Million - $3.66 Million	-121,412 Reduced 22.02%	429,993 $10.5 Million
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $11.9 Million - $17.2 Million	-572,661 Reduced 50.95%	551,405 $15.4 Million
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $1.22 Million - $1.58 Million	-51,131 Reduced 4.35%	1,124,066 $27 Million
Q2 2019 Aug 15, 2019	BUY	$22.1 - $28.56 $26 Million - $33.6 Million	1,175,197 New	1,175,197 $33.5 Million

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Veracyte, Inc. Transaction History